KDP

Why Are People Selling Their KDP Shares?

This afternoon we watched Keurig Dr Pepper drop -1.5% to a price of $29.77 per share. The large-cap Beverages company is now trading -23.07% below its average target price of $38.69. Analysts have set target prices ranging from $30.0 to $45.0 per share for Keurig Dr Pepper, and have given the stock an average rating of buy.

Keurig Dr Pepper's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.3. The company's insiders own 31.62% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 58.2%. In conclusion, we believe there is positive market sentiment regarding Keurig Dr Pepper.

Institutions Invested in Keurig Dr Pepper

Date Reported Holder Percentage Shares Value
2023-06-30 Capital World Investors 6% 80,618,799 $2,399,618,503
2023-06-30 Vanguard Group Inc 5% 76,706,305 $2,283,163,121
2023-06-30 Blackrock Inc. 5% 70,845,324 $2,108,711,025
2023-06-30 FMR, LLC 4% 53,755,421 $1,600,030,073
2023-06-30 Capital International Investors 4% 51,604,096 $1,535,995,885
2023-06-30 Wellington Management Group, LLP 3% 41,504,415 $1,235,378,887
2023-06-30 State Street Corporation 3% 37,359,724 $1,112,012,162
2023-06-30 Geode Capital Management, LLC 1% 16,604,177 $494,223,318
2023-06-30 Boston Partners 1% 15,720,251 $467,913,261
2023-06-30 T. Rowe Price Investment Management, Inc. 1% 15,588,901 $464,003,628
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS